Score
31
Technically Bearish
Advice
GlaxoSmithKline Pharmaceuticals Share Price - 1 Year Trend
GlaxoSmithKline Pharmaceuticals Price Change Analysis
-
P/E Ratio
15.1
-
PEG Ratio
0
-
Market Cap Cr
25407.5
-
Price to Book Ratio
158.1
-
EPS
99.5
-
Dividend
900 ()
-
Relative Strength Index
42.25
-
Money Flow Index
52.59
-
MACD Signal
-6.88
-
Average True Range
30.43
Investment Ratings
-
Master Rating:
-
EPS Strength
Price Strength
Buyer Demand
Group Rank
Result Highlights
GlaxoSmithKline Pharmaceuticals Synopsis
NSE-Medical-Diversified
Glaxosmithkline Phar is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3193.74 Cr. and Equity Capital is Rs. 169.41 Cr. for the Year ended 31/03/2021. GlaxoSmithKline Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 13/11/1924 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1924PLC001151 and registration number is 001151.-
Market Cap
25,407.51
-
Sales
3,364.89
-
Shares in Float
-
No of Funds
192
-
Yield
2
-
Book Value
9.49
-
U/D Vol Ratio
1.7
-
LTDebt/Equity
-
Alpha
0
-
Beta
0.46
| Owner Name | Jun-21 |
|---|---|
| Promoters | 75% |
| Mutual Funds | 4.07% |
| Foreign Portfolio Investors | 1.61% |
| Financial Institutions/ Banks | 1.44% |
| Individual Investors | 10.86% |
| Others | 7.02% |
| Name | Designation |
|---|---|
| Ms. R S Karnad | Chairperson |
| Mr. Sridhar Venkatesh | Managing Director |
| Dr.(Ms.) S Maheshwari | Director |
| Mr. S Williams | Director |
| Mr. P V Bhide | Director |
| Mr. N Kaviratne | Director |
| Mr. M Dawson | Director |
| Mr. A N Roy | Director |
| Mr. D Sundaram | Director |
| Ms. P Thakur | Director |
GlaxoSmithKline Pharmaceuticals Forecast
Price Estimates
Eps And Sales Estimates
GlaxoSmithKline Pharmaceuticals Financials
- Quarterly P&L
- Annual P&L
- Cash Flow
- Balance Sheet
- Ratios
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
CURRENT PRICE
EMA
GlaxoSmithKline Pharmaceuticals Resistance and Support
GlaxoSmithKline Pharmaceuticals Delivery and Volume
GlaxoSmithKline Pharmaceuticals Price Change Analysis
Corporate Action
Similar Stocks
| Company Name | 52 Week () |
Market Price () | Volume |
|---|